Adicet Bio, Inc.
ACETNext catalyst
No upcoming catalyst in our data
No upcoming FDA decision, filing or trial readout is on file for ACET. That does not mean none is planned.
Get an email about ACET's next catalysts
Track Adicet Bio (ACET) and we email you when an FDA date moves, 7 days and 1 day before the decision when the exact day is known, and when it is announced. Free account, no card.
0 upcoming, 2 past
No catalysts found.
Market Overview
Stock performance and key metrics
| Drug Name | Phase | Indication | Designations | Patent |
|---|---|---|---|---|
ADI-270 | Phase 2 | Clear Cell Renal Cell Carcinoma | - | - |
Frequently asked questions
What is in Adicet Bio, Inc.'s drug pipeline?→
CatalystAlert tracks 1 drug candidate in Adicet Bio, Inc.'s (ACET) pipeline across Phase 2. Its lead program is ADI-270 (Phase 2). Each drug's phase, indication and upcoming catalysts are listed on this page.
When is Adicet Bio, Inc.'s next FDA catalyst?→
CatalystAlert tracks every upcoming catalyst for Adicet Bio, Inc. (ACET) — PDUFA decision dates, Phase 1/2/3 trial readouts, FDA advisory committee meetings and NDA/BLA filings — each confidence-rated as confirmed, estimated or AI-detected.
How do I track ACET biotech catalysts?→
Add ACET to your CatalystAlert watchlist for alerts ahead of each catalyst, and follow Adicet Bio, Inc.'s live catalyst calendar, drug pipeline and clinical-trial timeline on this page — sourced from ClinicalTrials.gov, FDA and SEC filings.